Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
LifeMD, Inc. stock logo
LFMD
LifeMD
$9.94
-4.5%
$12.14
$3.99
$15.84
$473.11M1.72952,678 shs1.10 million shs
PACS Group, Inc. stock logo
PACS
PACS Group
$10.62
-4.0%
$11.71
$8.28
$43.92
$1.69B0.88488,840 shs625,371 shs
Progyny, Inc. stock logo
PGNY
Progyny
$22.49
-4.3%
$22.11
$13.39
$27.15
$2.02B1.321.01 million shs1.21 million shs
Veracyte, Inc. stock logo
VCYT
Veracyte
$23.64
+0.6%
$26.23
$19.73
$47.32
$1.84B1.971.97 million shs1.74 million shs
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
LifeMD, Inc. stock logo
LFMD
LifeMD
-4.51%-7.02%-23.12%+37.10%+39.41%
PACS Group, Inc. stock logo
PACS
PACS Group
-3.63%-9.23%-18.75%+5.25%-70.29%
Progyny, Inc. stock logo
PGNY
Progyny
-4.34%-2.68%+5.89%-3.19%-20.25%
Veracyte, Inc. stock logo
VCYT
Veracyte
+0.55%-6.38%-14.29%-22.11%-1.50%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
LifeMD, Inc. stock logo
LFMD
LifeMD
2.4384 of 5 stars
3.52.00.00.02.51.70.6
PACS Group, Inc. stock logo
PACS
PACS Group
3.0969 of 5 stars
3.43.00.00.01.40.01.9
Progyny, Inc. stock logo
PGNY
Progyny
2.0349 of 5 stars
2.31.00.00.03.62.51.3
Veracyte, Inc. stock logo
VCYT
Veracyte
2.8967 of 5 stars
3.40.00.04.34.00.00.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
LifeMD, Inc. stock logo
LFMD
LifeMD
3.00
Buy$13.8639.41% Upside
PACS Group, Inc. stock logo
PACS
PACS Group
2.86
Moderate Buy$34.29222.84% Upside
Progyny, Inc. stock logo
PGNY
Progyny
2.67
Moderate Buy$24.8210.35% Upside
Veracyte, Inc. stock logo
VCYT
Veracyte
2.70
Moderate Buy$40.9073.01% Upside

Current Analyst Ratings Breakdown

Latest LFMD, PGNY, VCYT, and PACS Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/17/2025
Progyny, Inc. stock logo
PGNY
Progyny
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetHold ➝ Hold$24.00 ➝ $27.00
7/14/2025
LifeMD, Inc. stock logo
LFMD
LifeMD
KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$12.00 ➝ $14.00
7/10/2025
LifeMD, Inc. stock logo
LFMD
LifeMD
Lake Street Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$12.00 ➝ $18.00
7/8/2025
Progyny, Inc. stock logo
PGNY
Progyny
Leerink Partnrs
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Strong-Buy
7/8/2025
Progyny, Inc. stock logo
PGNY
Progyny
Leerink Partners
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeMarket Perform ➝ Outperform$28.00
6/18/2025
LifeMD, Inc. stock logo
LFMD
LifeMD
BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$15.00 ➝ $18.00
5/12/2025
Progyny, Inc. stock logo
PGNY
Progyny
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetHold ➝ Hold$23.00 ➝ $21.00
5/8/2025
Veracyte, Inc. stock logo
VCYT
Veracyte
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$49.00 ➝ $42.00
5/8/2025
Veracyte, Inc. stock logo
VCYT
Veracyte
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$51.00 ➝ $41.00
(Data available from 8/2/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
LifeMD, Inc. stock logo
LFMD
LifeMD
$212.45M2.13N/AN/A($0.09) per share-110.44
PACS Group, Inc. stock logo
PACS
PACS Group
$3.11B0.52N/AN/AN/A
Progyny, Inc. stock logo
PGNY
Progyny
$1.17B1.65$0.33 per share68.13$4.96 per share4.53
Veracyte, Inc. stock logo
VCYT
Veracyte
$445.76M4.15$1.04 per share22.67$15.17 per share1.56
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
LifeMD, Inc. stock logo
LFMD
LifeMD
-$18.88M-$0.34N/A82.83N/A-4.58%N/A-15.19%8/6/2025 (Estimated)
PACS Group, Inc. stock logo
PACS
PACS Group
$112.87MN/A0.005.97N/AN/AN/AN/A8/11/2025 (Estimated)
Progyny, Inc. stock logo
PGNY
Progyny
$54.34M$0.5739.4634.602.364.33%10.90%7.20%8/7/2025 (Estimated)
Veracyte, Inc. stock logo
VCYT
Veracyte
$24.14M$0.4157.6632.83N/A7.13%6.14%5.60%8/6/2025 (Estimated)

Latest LFMD, PGNY, VCYT, and PACS Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/11/2025Q2 2025
PACS Group, Inc. stock logo
PACS
PACS Group
$0.45N/AN/AN/AN/AN/A
8/7/2025Q2 2025
Progyny, Inc. stock logo
PGNY
Progyny
$0.42N/AN/AN/A$315.70 millionN/A
8/6/2025Q2 2025
LifeMD, Inc. stock logo
LFMD
LifeMD
-$0.02N/AN/AN/A$66.17 millionN/A
8/6/2025Q2 2025
Veracyte, Inc. stock logo
VCYT
Veracyte
$0.31N/AN/AN/A$120.90 millionN/A
5/8/2025Q1 2025
Progyny, Inc. stock logo
PGNY
Progyny
$0.45$0.17-$0.28$0.17$307.86 million$324.04 million
5/6/2025Q1 2025
LifeMD, Inc. stock logo
LFMD
LifeMD
-$0.04$0.01+$0.05$0.01$62.47 million$65.70 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
LifeMD, Inc. stock logo
LFMD
LifeMD
N/AN/AN/AN/AN/A
PACS Group, Inc. stock logo
PACS
PACS Group
N/AN/AN/AN/AN/A
Progyny, Inc. stock logo
PGNY
Progyny
N/AN/AN/AN/AN/A
Veracyte, Inc. stock logo
VCYT
Veracyte
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
LifeMD, Inc. stock logo
LFMD
LifeMD
N/A
0.82
0.77
PACS Group, Inc. stock logo
PACS
PACS Group
N/AN/AN/A
Progyny, Inc. stock logo
PGNY
Progyny
N/A
2.39
2.39
Veracyte, Inc. stock logo
VCYT
Veracyte
N/A
5.10
4.78

Institutional Ownership

CompanyInstitutional Ownership
LifeMD, Inc. stock logo
LFMD
LifeMD
35.52%
PACS Group, Inc. stock logo
PACS
PACS Group
N/A
Progyny, Inc. stock logo
PGNY
Progyny
94.93%
Veracyte, Inc. stock logo
VCYT
Veracyte
N/A

Insider Ownership

CompanyInsider Ownership
LifeMD, Inc. stock logo
LFMD
LifeMD
18.40%
PACS Group, Inc. stock logo
PACS
PACS Group
N/A
Progyny, Inc. stock logo
PGNY
Progyny
9.40%
Veracyte, Inc. stock logo
VCYT
Veracyte
1.40%
CompanyEmployeesShares OutstandingFree FloatOptionable
LifeMD, Inc. stock logo
LFMD
LifeMD
23045.45 million37.09 millionOptionable
PACS Group, Inc. stock logo
PACS
PACS Group
32,433152.40 millionN/AOptionable
Progyny, Inc. stock logo
PGNY
Progyny
31085.72 million77.66 millionOptionable
Veracyte, Inc. stock logo
VCYT
Veracyte
79078.32 million77.22 millionOptionable

Recent News About These Companies

Veracyte (VCYT) to Release Quarterly Earnings on Wednesday
Veracyte (NASDAQ:VCYT) Shares Gap Up - What's Next?
Veracyte (VCYT) Soars 7% on S&P SmallCap 600 Inclusion
Veracyte (NASDAQ:VCYT) Shares Gap Up - Time to Buy?

New MarketBeat Followers Over Time

Media Sentiment Over Time

LifeMD stock logo

LifeMD NASDAQ:LFMD

$9.94 -0.47 (-4.51%)
Closing price 08/1/2025 04:00 PM Eastern
Extended Trading
$9.90 -0.04 (-0.45%)
As of 08/1/2025 07:51 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States. The company offers telehealth platform comprising RexMD, a men's telehealth brand that provides access to virtual medical treatment for a variety of men's health needs from licensed physician; ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss; NavaMD, a female-oriented tele-dermatology that offers virtual medical treatment from dermatologists and other providers; and prescription oral and compounded topical medications to treat aging and acne; and Cleared which provides personalized treatments for allergy, asthma and immunology, including in-home tests for both environmental and food allergies, prescriptions for allergies and asthma and immunotherapies for treating chronic allergies. It also provides LifeMD PC, a direct-to-consumer virtual primary care which includes 24/7 access to a provider for their primary care, urgent care, and chronic care needs; and offers virtual consultations and treatment, prescription medications, diagnostics and imaging, wellness coaching, and more. In addition, the company offers PDFSimpli, an online software as a service platform that allows users to create, edit, convert, sign, and share PDF documents; ResumeBuild which provides digital resume and cover letter services; SignSimpli, a digital signature platform; and LegalSimpli, a provider of legal forms for consumers and small businesses. It sells its products directly to consumers and through e-commerce platforms, as well as through third party partner channels. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was incorporated in 1994 and is headquartered in New York, New York.

PACS Group stock logo

PACS Group NYSE:PACS

$10.62 -0.44 (-3.98%)
Closing price 08/1/2025 03:59 PM Eastern
Extended Trading
$10.62 0.00 (0.00%)
As of 08/1/2025 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

PACS Group, Inc., through its subsidiaries, operates skilled nursing facilities and assisted living facilities in the United States. The company also provides senior care and independent facilities. It engages in the acquisition, ownership, and leasing of health care-related properties. The company was founded in 2013 and is based in Farmington, Utah.

Progyny stock logo

Progyny NASDAQ:PGNY

$22.49 -1.02 (-4.34%)
Closing price 08/1/2025 04:00 PM Eastern
Extended Trading
$22.24 -0.25 (-1.11%)
As of 08/1/2025 05:16 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides assistance service programs where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.

Veracyte stock logo

Veracyte NASDAQ:VCYT

$23.64 +0.13 (+0.55%)
Closing price 08/1/2025 04:00 PM Eastern
Extended Trading
$23.66 +0.02 (+0.09%)
As of 08/1/2025 07:53 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Veracyte, Inc. engages in the research, development and commercialization of diagnostic products. The firm's portfolio includes Afirma, Percepta, and Envisia. It intends to treat thyroid cancer, improve lung cancer screening, and clarify the diagnosis of idiopathic pulmonary fibrosis. The company was founded by Bonnie H. Anderson and Y. Douglas Dolginow on August 15, 2006 and is headquartered in South San Francisco, CA.